To study whether the change of urine osmotic pressure after administration of imidafenacin for over active bladder patients with nocturia could be the prediction of its antidiuretic effectiveness.

To study whether the change of urine osmotic pressure after administration of imidafenacin for over active bladder patients with nocturia could be the prediction of its antidiuretic effectiveness. - The antidiuretic effectiveness of imidafenacin for patients with nocturia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1091220405

Enrollment

Registered

2019-01-17

Start date

2019-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

over active bladder

Interventions

Intervention type:DRUG Name of intervention:imidafenacin Dose form / Japanese Medical Device Nomenclature:TABLET Route of administration / Site of application:ORAL Dose per administration:0.1 mg Dosin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: over active bladder patients with nocturia

Exclusion criteria

Exclusion criteria: the patients with acute urinary tract infections, urinary retention, closed angle glaucoma,severe heart failure, using anticholinergic agents, beta-3stimulator, urethral and ureteral catheter

Design outcomes

Primary

Measure	Time frame
urine osmotic pressure	—

Secondary

Measure	Time frame
IPSS, OABSS, urine osmotic pressure, urinary flow, residual urine volume, nocturnal polyuria index, sodium and creatinine level of casual urine specimen	—

Countries

Japan

Contacts

Public ContactMamoru Hashimoto

Kindai University, Faculty of Medicine

hashimot@med.kindai.ac.jp+81-72-366-0221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026